SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-005666
Filing Date
2024-02-28
Accepted
2024-02-28 12:40:36
Documents
1
Period of Report
2024-02-26

Document Format Files

Seq Description Document Type Size
1 form4-02282024_050227.html 4  
1 form4-02282024_050227.xml 4 3916
  Complete submission text file 0001415889-24-005666.txt   5387
Mailing Address 44 MILTON AVENUE ALPHARETTA GA 30009
Business Address 44 MILTON AVENUE ALPHARETTA GA 30009 8666208655
Virios Therapeutics, Inc. (Issuer) CIK: 0001818844 (see all company filings)

IRS No.: 854314201 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 44 MILTON AVENUE ALPHARETTA GA 30009
Business Address
Duncan Gregory Scott (Reporting) CIK: 0001831127 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39811 | Film No.: 24692590